| Trial ID: | L0379 |
| Source ID: | NCT00483275
|
| Associated Drug: |
Alfacalcidol
|
| Title: |
Fall Prevention by Alfacalcidol and Training
|
| Acronym: |
SPALT
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Accidental Falls|Chronic Renal Insufficiency|Aged
|
| Interventions: |
DRUG: Alfacalcidol|BEHAVIORAL: Balance, gait and strength training|BEHAVIORAL: Patient education
|
| Outcome Measures: |
Primary: Number of fallers, One year | Secondary: Number of falls, One year|Number of fractures, One year|Performance in balance and mobility, One year|Fear of falling, One year|Rate of hypercalcaemia, One year
|
| Sponsor/Collaborators: |
Sponsor: Ruhr University of Bochum | Collaborators: Teva Branded Pharmaceutical Products R&D, Inc.
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
484
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2007-06
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2011-07-21
|
| Locations: |
Klinik für Altersmedizin und Frührehabilitation, Marienhospital, Ruhr-Universität Bochum, Herne, NRW, 44627, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00483275
|
